Back
C4 Therapeutics Stock Predictions
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Sell
20
CCCC
C4 Therapeutics
Last Price:
5.51
Seasonality Move:
60.44%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!C4 Therapeutics Stock Forecast
- Over the next 52 weeks, C4 Therapeutics has on average historically risen by 56.5% based on the past 4 years of stock performance.
- C4 Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is C4 Therapeutics Stock Undervalued?
The current C4 Therapeutics [CCCC] share price is $5.89. The Score for CCCC is 20, which is 60% below its historic median score of 50, and infers higher risk than normal. - CCCC is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will C4 Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, C4 Therapeutics has on average historically risen by 56.5% based on the past 4 years of stock performance.
C4 Therapeutics Stock Rating
Sell
20
C4 Therapeutics (CCCC)
is a Sell
Is C4 Therapeutics overpriced?
- C4 Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
C4 Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
c4therapeutics.com
52-Week Data
52-Week High:
11.88
52-Week Low:
1.06
Prediction Charts
Market Cap:
415.77M
Price in USD:
5.89
Volume:
827.23K
Beta:
3.06
Technical Analysis
SMA50:
5.95
SMA100:
5.85
SMA200:
6.47
52-Wk Change:
242.44%
Stock Predictions
-
Is C4 Therapeutics stock public?
Yes, C4 Therapeutics is a publicly traded company. -
What is the C4 Therapeutics stock quote today?
The C4 Therapeutics stock price is 5.89 USD today. -
How to buy C4 Therapeutics stock online?
You can buy C4 Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Oct-23 | 6.18 | 6.04 | 6.36 | 5.90 |
| Oct-24 | 6.10 | 5.95 | 6.14 | 5.83 |
| Oct-25 | 5.98 | 5.89 | 6.10 | 5.81 |
| Oct-28 | 6.04 | 6.00 | 6.27 | 5.91 |
| Oct-29 | 5.94 | 5.90 | 5.96 | 5.75 |
| Oct-30 | 5.83 | 5.53 | 5.89 | 5.53 |
| Oct-31 | 5.68 | 5.33 | 5.77 | 5.22 |
| Nov-1 | 5.59 | 5.61 | 5.96 | 5.44 |
| Nov-4 | 5.58 | 6.45 | 6.52 | 5.41 |
| Nov-5 | 6.20 | 6.09 | 6.37 | 5.84 |
| Nov-6 | 6.37 | 5.97 | 6.45 | 5.87 |
| Nov-7 | 6.00 | 6.04 | 6.25 | 5.93 |
| Nov-8 | 6.06 | 6.06 | 6.17 | 5.89 |
| Nov-11 | 6.12 | 5.89 | 6.20 | 5.76 |
C4 Therapeutics Earnings
C4 Therapeutics Earnings Report: Per Share C4 Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
C4 Therapeutics Forecast Revenue Growth
C4 Therapeutics Stock Analysis: Historical quarterly revenues per share for C4 Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.35 per share.
* C4 Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.